Skip to main content
. 2014 Oct 24;5(23):12247–12259. doi: 10.18632/oncotarget.2627

Table 2. Clinicopathologic and biologic factors affecting survival rate.

Univariate analysis Multivariate analysis
Variable RR 95% CI P value RR 95% CI P value
Age at diagnosis > 1.5 year versus ≤ 1.5 year 4.098 1.938 – 8.662 0.001 1.242 0.459 – 3.357 0.670
Clinical stage Advanced (3 & 4) versus early (1, 2 and 4S) 13.328 4.146 – 42.842 < 0.001 5.113 1.314 – 19.894 0.019
MYCN Amplified versus non-amplified 3.457 2.048 – 5.834 < 0.001 2.034 1.135 – 3.645 0.017
GALNT2 expression Negative versus positive 4.320 2.265 – 8.239 < 0.001 2.495 1.248 – 4.987 0.010
INPC histology Unfavorable versus favorable 3.720 2.115 – 6.543 < 0.001 2.220 1.193 – 4.133 0.012
Primary tumor site Adrenal versus non-adrenal 1.299 0.764 – 2.211 0.334 ND ND ND

Abbreviations: INPC, International Neuroblastoma Pathology Classification; RR, risk ratio; 95% CI, 95% confidence interval; ND, not done.